A benign prostatic hypertrophy with outflow obstruction is a condition characterised by the enlargement of the prostate, so much so that it obstructs the flow of urine. The condition may also affect the nerves of the prostate, and this can result in various symptoms such as increased urinary frequency, nocturia (urinating frequently at night), hesitancy (difficulty urinating), and the inability to empty the bladder completely. Patients who are suspected of having a benign prostatic hypertrophy should seek specialised medical treatment immediately to prevent lasting damage to the prostate and kidneys.
Fortunately, patients can take advantage of the low cost but advanced and innovative treatments for their condition by travelling to Southeast Asia. ASEAN countries like Singapore, Thailand, and Malaysia boast an impressive portfolio of modern medical therapies, including advanced ultrasonography, which can accurately determine a person’s prostate size and degree of hypertrophy, if present. Once diagnosed, patients with benign prostatic hypertrophy can be treated using medical therapy and conventional surgery, such as an open prostatectomy. They can also take advantage of minimally invasive procedures in Southeast Asia. The region is reputed worldwide for its focus on these modern methods, which have fewer risks and complications than conventional surgery. Some examples are transurethral microwave therapy that contracts the prostate by causing cell death using heat, and the use of a prostatic stent to treat outflow obstruction. All these procedures are performed using smaller incisions and significantly reduce the risk of pain, bleeding, and infection.
The best part of going to Southeast Asia for treatment, however, is definitely the lower, more affordable cost of medical care. While advanced treatment procedures cost quite a lot in the US and Europe, the same procedures go for up to 75% cheaper in ASEAN countries. Also, the waiting period is significantly shorter in Southeast Asia than in Western countries.